Testing effectiveness (Phase 2)WithdrawnNCT03593421
What this trial is testing
Phase 2 Dose Finding sPIF in Patients With High Panel Reactive Antibodies
Who this might be right for
Panel Reactive Antibodies
Christopher O'Brien, MD
Showing 4 of 0 results